In this model, TAMs derived from PyMT mice bearing homozygous null CCL5 (CCL5−/−) exhibited a cancer-suppressing phenotype compared to TAMs in control (CCL5+/+) PyMT mice. This evidence concerns the gene CCL5 and cancer.